4Robinson S, Cohen AR. Cowden disease and Lhermitte-Duclos disease: characterization of a new phakomatosis. Neurosurgery, 2000,46:371-383.
5Kumar R, Vaid VK, Kalra SK. Lhermitte-Duclos disease. Chi- lds Nerv Syst, 2007, 23:729-732.
6Spaargaren L, Cras P, Bomhof MA, et al. Contrast enhancement in Lhermitte-Duclos disease of the cerebellum: correlation of imaging with neuropathology in two cases. Neuroradiology,2003, 45:381-385.
7Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classifi-cation of Tumours of the Central Nervous System, Fourth Edition. Lyon : International Agency for Research on Cancer ( IARC ) Press, 2007.
8National Comprehensive CarLcer Network. I (2008). The NCCN genetic/familial high-risk assessment : Breast and ovarian (version 1. 2008 ). Clinical Practice Guidelines in Oncology. Retrieved June 7 2008, from http ://www. nccn. org.
9Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns, 2009,18 : 13-27.
10Douglas-Akinwande AC, Payner TD, Hattab EM. Medullobla- stoma mimicking Lhermitte-Duclos disease on MRI and CT. Clin Neurol Neurosurg,2009,111:536-539.
